The
advisory board for Future Forward includes:
Elizabeth
Altman - Doctoral
Student, Harvard Business School; former Vice President, Business Development, Motorola
Mobile Devices
David
Beisel - Partner, NextView Ventures
Joe
Caruso - President, Bantam Group
Gregg
Favalora - CTO, Optics For Hire
Gabor
Garai - Partner, Foley & Lardner LLP
Shayne
Gilbert - Founder, Silverweave;
author, 90 Days to Launch
Christopher
Herot - CEO, SBR Health
Eric
Hjerpe - Partner, Kepha Partners
Scott
Kirsner - Innovation Economy
columnist, The
Boston Globe
Sue
Parente - Managing Partner, Tier One Partners
Alyssa
Stern - Vice
President, Future
Forward Events, LLC
Future
Forward is one of three high-level programs produced by
Future Forward Events, LLC. The other two conferences
are:
Nantucket
Conference on Entrepreneurship and Innovation
Started in 2000, the Nantucket Conference on Entrepreneurship
& Innovation, www.nantucketconference.com,
is an annual sold-out gathering of the New England
region's most influential high-tech entrepreneurs,
executives and investors. Speakers at the
Nantucket Conference have included Lotus founder Mitch
Kapor; Motorola CEO Ed Zander; Celera Genomics founder
Craig Venter; 3Com Corp founder Bob Metcalfe; Dan
Bricklin, co-inventor of the spreadsheet; and Forrester
Research CEO George Colony.
Convergence:
The Life Sciences Leaders Forum
Launched in 2004, Convergence, www.convergenceforum.com,
brings together high-level life sciences players from
around the Northeast to discuss and debate the most
pressing topics of interest to the industry - topics
like forging strong corporate partnerships; attracting
funding from private and public sources; building
successful research organizations; streamlining product
development and approval; understanding the coming
convergence of biology, software, and medical devices;
and staying ahead of regulatory changes. Past
speakers have included Robert Langer, ScD, Kenneth J.
Germeshausen Professor of Chemical and Biomedical
Engineering, MIT, Dean Kamen, President, DEKA Research,
Senator Edward Kennedy, and Henri Termeer, CEO of
Genzyme.
